1. Home
  2. AXGN vs CCCC Comparison

AXGN vs CCCC Comparison

Compare AXGN & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Axogen Inc.

AXGN

Axogen Inc.

HOLD

Current Price

$32.83

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$2.13

Market Cap

240.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AXGN
CCCC
Founded
N/A
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
240.3M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
AXGN
CCCC
Price
$32.83
$2.13
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$33.67
$7.25
AVG Volume (30 Days)
1.0M
2.0M
Earning Date
10-29-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$214,709,000.00
$30,108,000.00
Revenue This Year
$21.57
N/A
Revenue Next Year
$15.79
N/A
P/E Ratio
N/A
N/A
Revenue Growth
18.72
N/A
52 Week Low
$9.22
$1.09
52 Week High
$34.24
$4.26

Technical Indicators

Market Signals
Indicator
AXGN
CCCC
Relative Strength Index (RSI) 69.16 38.17
Support Level $28.98 $2.00
Resistance Level $32.77 $2.69
Average True Range (ATR) 1.74 0.18
MACD -0.10 -0.06
Stochastic Oscillator 78.63 13.02

Price Performance

Historical Comparison
AXGN
CCCC

About AXGN Axogen Inc.

Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patients' lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. Its degrader medicines are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT1946, and CFT8919.

Share on Social Networks: